53.61% -0.4651

Vaccinex Inc (VCNX)

개요 뉴스 가격 이력 Financials VCNX 왜 하락? 토론 예측 주식 분할

Relative Volume:

Vaccinex Inc Stock (VCNX) Company Profile

Vaccinex Inc

Healthcare (1136)

Biotechnology (633)

최신 SEC 제출 서류

VCNX's Discussions on Twitter

VCNX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
VCNX Vaccinex Inc	0.6617	0	0	-22.01M	-18.31M	-85.40
ARGX Argen X Se Adr	918.97	57.24B	3.06B	1.28B	447.35M	19.67
VRTX Vertex Pharmaceuticals Inc	437.06	110.12B	11.74B	3.68B	3.34B	14.19
INSM Insmed Inc	196.99	42.10B	447.02M	-1.18B	-906.14M	-6.1812
ONC Beone Medicines Ltd Adr	358.67	41.68B	4.98B	69.59M	525.67M	0.5197
REGN Regeneron Pharmaceuticals Inc	710.88	74.02B	14.25B	4.58B	3.88B	41.77

Vaccinex Inc Stock (VCNX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-09-23	다운그레이드	BTIG Research	Buy → Neutral
2018-09-04	개시	Ladenburg Thalmann	Buy

Vaccinex Inc 주식(VCNX)의 최신 뉴스

Vaccinex Inc (VCNX) 재무 분석

Vaccinex Inc (VCNX)

Vaccinex Inc Stock (VCNX) Company Profile

VCNX을(를) 다른 주식과 비교

Vaccinex Inc Stock (VCNX) Upgrades & Downgrades

Vaccinex Inc 주식(VCNX)의 최신 뉴스

Vaccinex (NASDAQ:VCNX) Trading 4.2% Higher – Time to Buy? - Defense World

Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga

Vaccinex (NASDAQ:VCNX) Stock Price Down 5.7% – Time to Sell? - Defense World

Contrasting Vaccinex (NASDAQ:VCNX) & Palatin Technologies (PINK:PTNT) - Defense World

NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight - PR Newswire UK

What sets apart Novavax option from other COVID-19 vaccines - American Medical Association

Vaccinex, Inc. (NASDAQ:VCNX) Sees Significant Growth in Short Interest - Defense World

GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire

Senators from both parties grilled RFK Jr. on vaccines and more - NPR

Vaccine Development - Gates Foundation

TR | OpenAI4o Maintains Vaccinex(VCNX.US) With Hold Rating, Cuts Target Price to $0.5 - 富途牛牛

Head to Head Survey: Aerovate Therapeutics (NASDAQ:AVTE) vs. Vaccinex (NASDAQ:VCNX) - Defense World

Vaccinex (NASDAQ:VCNX) Trading 26.3% Higher – Here’s Why - Defense World

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - India Shorts

Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunotherapies | DelveInsight - The Malaysian Reserve

Huntington’s Disease Market to Expand Significantly by 2034, States DelveInsight Report | Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics - Barchart.com

Huntington's Disease Market To Expand Significantly By 2034, States Delveinsight Report Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics - Menafn

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust - GlobeNewswire

Alzheimer’s Therapeutics Market on Upward Trajectory Across - GlobeNewswire

Vaccinex (NASDAQ:VCNX) Shares Down 2.7% – Time to Sell? - Defense World

Alzheimer's Disease Clinical Trials 2025: EMA, PDMA, FDA - openPR.com

Vaccinex (NASDAQ:VCNX) Shares Down 2.4% – Time to Sell? - Defense World

Vaccinex presents promising cancer treatment data at ASCO By Investing.com - Investing.com India

Vaccinex to Report Promising New Clinical Results of Neoadjuvant - GuruFocus

Vaccinex presents promising cancer treatment data at ASCO - Investing.com

Vaccinex, Inc. to Present New Data on Pepinemab's Role in Enhancing Immune Responses in Head and Neck Cancer at ASCO 2025 - Nasdaq

Vaccinex to Report Promising New Clinical Results of - GlobeNewswire

Clinical Trial Success: New Drug Transforms Cold Tumors into Hot Immune Centers in Head and Neck Cancer - Stock Titan

Vaccinex (NASDAQ:VCNX) Stock Price Down 11.3% – Here’s What Happened - Defense World

AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle Challenging Antibody Drug Targets - ACCESS Newswire

Vaccinex reports pepinemab boosts immune response in cancer - Investing.com

Vaccinex director resigns, no disagreement cited - Investing.com

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On - Citeline News & Insights

Vaccinex plans Nasdaq exit as Alzheimer market pressure grows - Pharmaceutical Technology

Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market - Yahoo Finance

RFK Jr. says he's resigned from anti-vaccine nonprofit as he seeks nation's top health official job - AP News

Louisiana forbids public health workers from promoting COVID, flu and mpox shots : ShotsHealth News - NPR

VCNX Stock Price and Chart — OTC:VCNX - TradingView

United States shares lower at close of trade; Dow Jones Industrial Average down 0.61% - Investing.com India

Vaccinex, Inc. Faces Delisting from Nasdaq Due to Failure to Meet Continued Listing Standards - Quiver Quantitative

School Vaccine Mandates - Britannica

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - PR Newswire

Vaccinex inks multiple antibody discovery deals using ActivMAb By Investing.com - Investing.com UK

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire

Vaccinex Stock Spikes On Promising Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Stocktwits

Vaccinex exercises warrants for proceeds of $6.2M - Seeking Alpha

Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns - TipRanks

Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges - ACS Publications

Vaccinex says Alzheimer's candidate buoyed by additional early-stage data (NASDAQ:VCNX) - Seeking Alpha

VBI Vaccines to be delisted from Nasdaq following restructuring - Investing.com

Vaccinex Inc (VCNX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

VCNX과 유사한 종목